Psychological sweating in response to emotive stimuli like stress, anxiety and pain occurs over the whole body surface, but is most evident on the palms, soles, face and axilla. This is primarily a consequence of high eccrine sweat gland densities at these body sites. Cholinergic innervation is the primary effector eliciting activation of eccrine sweat glands during periods of acute psychological stress. A dual innervation pathway for eccrine glands (adrenergic and cholinergic) may augment increased sweat output, but this remains to be substantiated. Circulating catecholamines appear not to mediate eccrine gland activity, but may play a role in the activation of apocrine sweat glands. Apocrine sweating is strongly regulated by psychological stimuli and localised to those body sites hosting apocrine glands, with adrenergic peripheral pathways being the primary effector. Accordingly, in the axilla psychological sweating leads to increased sweat output and malodour formation, although this form of sweating at this body site is not observed until puberty.

Keywords:
Catecholamines, Emotional sweating, Innervation, Malodour, Stress
1.
Chalmers TM, Keele CA: The nervous and chemical control of sweating. Br J Dermatol 1952;64:43-54.
2.
Allen JA, Armstrong JE, Roddie IC: The regional distribution of psychological sweating in man. J Physiol 1973;235:749-759.
3.
Lindsay SL, Holmes S, Corbett AD, Harker M, Bovell DL: Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis. Br J Dermatol 2008;159:653-660.
4.
Martin A, Hellhammer J, Hero T, Max H, Terstegen L, Natsch A: Effective prevention of stress-induced sweating and axillary mal-odour formation in teenagers. Int J Cos Sci 2011;33:90-97.
5.
Sato K, Kang WH, Saga K, Sato KT: Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol 1989;20:537-563.
6.
Quinton PM, Elder HY, McEwan Jenkinson D, Bovell, DL: Structure and function of human sweat glands; in Laden K, Felger CB (eds): Antiperspirants and Deodorants. New York, Marcel Dekker, 1999, pp 17-57.
7.
Wilke K, Martin A, Terstegen L, Biel SS: A short history of sweat gland biology. Int J Cos Sci 2007;29:169-179.
8.
Bovell DL, Corbett, AD, Holmes S, MacDonald A, Harker M: The absence of apoeccrine glands in the human axilla has disease pathogenetic implications, including axillary hyperhidrosis. Brit J Dermatol 2007;156:1278-1286.
9.
Goldsmith LA: Biology of eccrine and apocrine sweat glands; in Fitzpatrick TB (ed): Dermatology in General Medicine. New York, McGraw-Hill, 1998, pp 155-164.
10.
Hwang K, Baik SH: Distribution of hairs and sweat glands on the bodies of Korean adults: a morphometric study. Acta Anat 1997;158:112-120.
11.
Szabó G: The regional anatomy of the human integument with special reference to the distribution of hair follicles, sweat glands and melanocytes. Phil Trans R Soc Lond B 1967;252:447-485.
12.
Sato K, Leidal R, Sato F: Morphology and development of an apoeccrine sweat gland in human axillae. Am J Physiol 1987;252:R166-R180.
13.
Sato K, Sato F: Defective beta-adrenergic response of cystic fibrosis sweat glands in vivo and in vitro. J Clin Invest 1984;73:1763-1771.
14.
Uno H: Sympathetic innervation of the sweat glands and piloerector muscle of macaques and human beings. J Invest Dermatol 1977;69:112-130.
15.
Randall WC, Kimura KK: The pharmacology of sweating. Pharma Rev 1955;7:365-397.
16.
Coon JM, Rothman S: The sweat response to drugs with nicotine-like action. J Pharmacol Exp Ther 1941;73:1-11.
17.
Connolly M, de Berker D: Management of primary hyperhidrosis. Am J Clin Dermatol 2003;4:681-697.
18.
Wada M: Sudorific action of adrenaline on the human sweat glands and determination of their excitability. Science 1950;111:376-377.
19.
Foster KG, Weiner JS: Effects of cholinergic and adrenergic blocking agents on the activity of the eccrine sweat glands. J Physiol (Lond) 1970;210:883-895.
20.
Foster KG, Ginsberg J, Weiner JS: Role of circulating catecholamines in human eccrine sweat gland control. Clin Sci 1970;39:823-832.
21.
Sato K, Sato F: Pharmacological responsiveness of isolated single eccrine sweat glands. Am J Physiol 1981;240:R44-R51.
22.
Sato K: Update on pharmacology of the eccrine sweat gland. Trends Pharmacol Sci 1984;5:391-393.
23.
Low PA, Opfer-Gehrking TL, Kihara M: In vivo studies on receptor pharmacology of the human eccrine sweat gland. Clin Aut Res 1992;2:29-34.
24.
Riedl B, Nischik M, Birklein F, Neudorfer B, Handwerker HO: Spatial extension of sudomotor axon reflex sweating in human skin. J Auton Nerv Sys 1998;69:83-88.
25.
Sato K, Sato F: Effect of VIP on sweat se-cretion and cAMP accumulation in isolated simian eccrine glands. Am J Physiol 1987;253:R935-R941.
26.
Bovell DL, Santic R, Kofler B, Hermann A, Wilson D, Corbett A, Lang R: Activation of chloride secretion via proteinase-activated receptor 2 in a human eccrine sweat gland cell line - NCL-SG3. Exp Dermatol 2008;17:505-511.
27.
Schlereth T, Dittmar JO, Seewald B, Hamm H: Peripheral amplification of sweating - a role for calcitonin gene-related peptide. J Physiol (Lond) 2006;576:823-832.
28.
Holub B, Brodowicz B, Bovell DL, Kofler B, Lang R: Galanin and its receptors as modulators of eccrine sweat gland physiology. Exp Dermatol 2012;21:e17-e18.
29.
Bovell DL, Lindsay SL, Holdsworth RJ: P2Y1, P2Y2, and P2Y4 receptor localisation in human hyperhidrotic eccrine sweat glands. Br J Surg 2003;90:1-6.
30.
Kumazawa K, Sobue G, Mitsuma T, Ogawa T: Modulatory effects of calcitonin gene-related peptide and substance P on human cholinergic sweat secretion. Clin Auton Res 1994;4:319-322.
31.
Berg TJ, Levy DM, Reid G, Abraham RR: The effects of vasoactive intestinal polypeptide and substance P on methacholine-induced sweating and vascular flare in diabetic neuropathy. Clin Auton Res 1995;5:159-164.
32.
Aoki T: Stimulation of human axillary apocrine sweat glands by cholinergic agents. J Invest Dermatol 1962;38:41-44.
33.
Shelley WB, Hurley HJ: The physiology of the human axillary apocrine sweat gland. J Invest Dermatol 1953;20:285-297.
34.
Sato K, Sato F: Sweat secretion by human axillary apoeccrine sweat gland in vitro. Am J Physiol 1987;252:R181-R187.
35.
Sato K: Pharmacological responsiveness of the isolated human axillary apocrine gland. Br J Dermatol 1980;103:235-243.
36.
Cacioppo JT, Berntson GG, Malarkey WB, Kiecolt-Glaser JK, Sheridan JF, Poehlmann, KM, Burleson, MH, Ernst JM, Hawkley LC, Glaser R: Autonomic, neuroendocrine, and immune responses to psychological stress: the reactivity hypothesis. Ann NY Acad Sci 1998;840:664-673.
37.
Herman JP, Ulrich-Lai YM: Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009;10:397-409.
38.
Ryan KK, Grayson BE, Jones KR, Schneider AL, Woods SC, Seeley RJ, Herman JP, Ulrich-Lai YM: Physiological responses to acute psychological stress are reduced by the PPARγ agonist rosiglitazone. Endocrinol 2012;153:1279-1287.
39.
Black PH: Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 2002;16:622-653.
40.
Machado-Moreira CA, Taylor NAS: Psychological sweating from glabrous and nonglabrous skin surfaces under thermoneutral conditions. Psychophysiology 2011;49:369-374.
41.
Storm H: Development of emotional sweating in preterms measured by skin conductance changes. Early Hum Dev 2001;62:149-158.
42.
Swaile DF, Elstun LT, Benzing KW: Clinical studies of sweat rate reduction by an over-the-counter soft-solid antiperspirant and comparison with a prescription antiperspirant product in male panellists. Br J Dermatol 2012;166(suppl 1):22-26.
43.
Boucsein W: Electrodermal Activity. New York, Plenum Press, 1992.
44.
Le Doux, J: The Psychological Brain. New York, Simon & Schuster, 1996.
45.
Kling A, Brothers L: The amygdala and social behavior; in Aggleton JP (ed): The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. New York, Wiley-Liss, 1992.
46.
Bohus B, Koolhaas JM, Luiten PGM, Luiten PGM, Korte SM, Roozendaal B, Wiersma A: The neurobiology of the central nucleus of the amygdala in relation to neuroendocrine and autonomic outflow. Prog Brain Res 1996;107:447-460.
47.
Bagshaw MH, Kimble DP, Pribram KH: The GSR of monkeys during operating and habitation and after ablation of the amygdala hippocampus and inferotemporal cortex. Neuropsychologia 1965;3:111-119.
48.
Lee GP, Arena JG, Meador KJ, Smith JR, Lo-ring DW, Flanigin HF: Change in autonomic responsiveness following bilateral amygdalotomy in humans. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:119-129.
49.
Asahina M, Suzuki A, Mori M, Kanesaka T, Hattori T: Emotional sweating response in a patient with bilateral amygdala damage. Int J Psychophysiol 2003;47:87-93.
50.
Asahina M, Fujinuma Y, Yamanaka Y, Fukushima T, Katagiri A, Ito S, Kuwabara S: Diminished psychological sweating in patients with limbic encephalitis. J Neurol Sci 2011;306:16-19.
51.
Mangina CA, Beuzeron-Mangina JH: Direct electrical stimulation of specific human brain structures and bilateral electrodermal activity. Int J Psychophysiol 1996;22:1-8.
52.
Homma S, Nakajima Y, Toma, S, Ito T, Shibata T: Intracerebral source localization of mental process-related potentials elicited prior to mental sweating response in humans. Neurosci Lett 1998;247:25-28.
53.
Champion RH: Sweat glands; in Champion RH, Gillman T, Rook AJ, Sims RT (eds): An Introduction to the Biology of the Skin. Philadelphia, Davis, 1970, pp 175-183.
54.
Kennard DW: The nervous regulation of the sweating apparatus of the human skin, and emotive sweating in thermal sweating areas. J Physiol 1963;165:457-467.
55.
Machado-Moreira CC, Taylor NA: Sudomotor responses from glabrous and non-glabrous skin during cognitive and painful stimulations following passive heating. Acta Physiol 2012;204:571-581.
56.
Machado-Moreira CC, McLennan PL, Lillioja S, van Dijk W, Caldwell JN, Taylor NA: The cholinergic blockade of both thermally and non-thermally induced human eccrine sweating. Exp Physiol 2012;97:930-942.
57.
Smith CJ, Havenith G: Body mapping of sweating patterns in male athletes in mild exercise-induced hyperthermia. Eur J Appl Physiol 2011;111:1391-1404.
58.
Ganong WF: Review of Medical Physiology, ed 11. Los Altos, Lange Medical Publications, 1983.
59.
Jensen D: The Human Nervous System. New York, Appleton-Century-Crofts, 1980.
60.
Guyton AC: Basic Human Neurophysiology, ed 3. Philadelphia, Saunders, 1981.
61.
Robertshaw D: Neuroendocrine control of sweat glands. J Invest Dermatol 1977;69:121-129.
62.
Noback CR, Demarest RJ: The Nervous System: Introduction and Review. New York, McGraw Hill, 1972.
63.
Edelberg R: Electrical activity of the skin: its measurement and uses in psychophysiology; in Greenfield J, Sternbach RA (eds): Hand Book of Psychophysiology. New York, Holt, Rhinehart & Winston, 1972, pp 367-418.
64.
Lader MH, Montagu JD: The psycho-galvanic reflex: a pharmacological study of the peripheral mechanism. J Neurol Neurosurg Psych 1962;25:126-133.
65.
Rowell LB: Reflex control of the cutaneous vasculature. J Invest Dermatol 1977;69:154-166.
66.
Johnson JM: Nonthermoregulatory control of human skin blood flow. J Appl Physiol 1986;61:1613-1622.
67.
Johnson JM, Brengelmann GL, Hales JR, Vanhoutte PM, Wenger CB: Regulation of the cutaneous circulation. Fed Proc 1986;45:2841-2850.
68.
Johnson JM, Proppe DW: Cardiovascular adjustments to heat stress; in Fregly MJ, Blatteis CM (eds): Handbook of Physiology. Oxford, Oxford University Press, 1996, pp 215-243.
69.
Kellogg DL: A physiological systems approach to human and mammalian thermoregulation: in vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol 2006;100:1709-1718.
70.
Johnson JM, Duane W, Proppe DW: Cardiovascular Adjustments to Heat Stress. Compr Physiol 2011(suppl 14):215-243.
71.
Charkoudian N, Johnson JM: Reflex control of cutaneous vasoconstrictor system is reset by exogenous female reproductive hormones. J Appl Physiol 1999;87:381-385.
72.
Kurzen H, Schallreuter KU: Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors. Exp Dermatol 2004;13(suppl 4):27-30.
73.
Kamijo YI, Lee K, Mack GW: Active cutaneous vasodilation in resting humans during mild heat stress. J Appl Physiol 2005;98:829-837.
74.
Sugenoya J, Ogawa T, Jmai K, Ohnishi N, Natsume K: Cutaneous vasodilation responses synchronize with sweat expulsions. Eur J Appl Physiol 1995;71:33-40.
75.
Darrow CW: Neural mechanisms controlling the palmar galvanic skin reflex and palmar sweating. Arch Neurol Psychiatry 1937;37:641-663.
76.
Harrison J, MacKinnon PC: Physiological role of the adrenal medulla in the palmar anhidrotic response to stress. J Appl Physiol 1966;21:88-92.
77.
Maple S, Bradshaw CM, Szabadi E: Pharmacological responsiveness of sweat gland in anxious patients and healthy volunteers. Br J Psychiatry 1982;141:154-161.
78.
Van den Brock MD, Bradshaw CM, Szabadi E: The effects of a psychological ‘stressor' and a raised ambient temperature on the pharmacological responsiveness of human eccrine sweat glands: implications for sweat gland hyper-responsiveness in anxiety states. Eur J Clin Pharmacol 1984;26:209-213.
79.
Buceta JM, Bradshaw CM, Szabadi E: Hyper-responsiveness of eccrine sweat glands to carbachol in anxiety neurosis: comparison of male and female patients. Br J Clin Pharmacol 1985;19:817-822.
80.
Lowe N, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, Naumann M, Offidani A, Vadoud J, Hamm H: The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol 2004;151:1115-1122.
81.
Glaser DA, Loss R, Beddingfield F, Coleman W: Four-year longitudinal data on the efficacy and safety of repeated botulinum toxin type A therapy for primary axillary hyperhidrosis. J Am Acad Dermatol 2007;56:AB61-AB61.
82.
Lennartsson A-K, Kushnir MM, Bergquist J, Billig H, Jonsdottir IH: Sex steroid levels temporarily increase in response to acute psychosocial stress in healthy men and women. Int J Psychophysiol 2012;84:246-253.
83.
Seoung S, Kim BS: Hyperhidrosis as the only manifestation of hyperandrogenism in an adolescent girl. Arch Dermatol 2000;136:430-431.
84.
Holzle E: Pathophysiology of sweating. Curr Probl Dermatol 2002;30:10-22.
85.
Adelman S, Taylor CR, Heglund NC: Sweating on paws and palms: what is its function? Am J Physiol 1975;229:1400-1402.
86.
Stroud LR, Salovey P, Epel ES: Sex differences in stress responses: social rejection versus achievement stress. Biol Psych 2002;52:318-327.
87.
Taylor SE, Klein LC, Lewis BP, Gruenewald TL, Gurung RA, Updegraff JA: Biobehavioural responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol Rev 2000;107:411-429.
88.
De Groot JH, Smeets MA, Kaldewaij A, Duijndam MJ, Semin GR: Chemosignals communicate human emotions. Psychol Sci 2012;23:1417-1424.
89.
Pause BM, Ohrt A, Prehn A, Ferstl R: Positive emotional priming of facial affect perception in females is diminished by chemosensory anxiety signals. Chem Senses 2004;29:797-805.
90.
Zernecke R, Haegler K, Kleemann AM, Albrecht J, Frank T, Linn J, Brückmann H, Wiesmann M: Effects of male anxiety che-mosignals on the evaluation of happy facial expressions. J Psychophysiol 2001;25:116-123.
91.
Zhou W, Chen D: Fear-related chemosignals modulate recognition of fear in ambiguous facial expressions. Psychol Sci 2009;20:177-183.
92.
Mujica-Parodi LR, Strey HH, Frederick B, Savoy R, Cox D, Botanov Y, Tolkunov D, Rubin D, Weber J: Chemosensory cues to conspecific emotional stress activate amygdala in humans. PLoS One 2009;4:e6415.
93.
Rubin D, Botanov Y, Hajcak G, Mujica-Parodi LR: Second-hand stress: inhalation of stress sweat enhances neural response to neutral faces. Soc Cogn Affect Neurosci 2012;7:208-212.
94.
Pause BM: Processing of body odor signals by the human brain. Chemosens Percept 2012:5;55-63.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.